Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9515)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2016 (publication date) through Jan 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Moole H, Patel J, Ahmed Z, Duvvuri A, Vennelaganti S, Moole V, Dharmapuri S, Boddireddy R, Yedama P, Bondalapati N, Uppu A, Vennelaganti P, Puli S. Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists. World J Gastroenterol 2016; 22(39): 8831-8843 [PMID: 27818599 DOI: 10.3748/wjg.v22.i39.8831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i39/8831.htm |
| Number | Citing Articles |
| 1 |
Won-Tak Choi, Gregory Y. Lauwers, Elizabeth A. Montgomery. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Modern Pathology 2022; 35(8): 1000 doi: 10.1038/s41379-022-01056-0
|
| 2 |
Barbara Braden, Evonne Jones-Morris. How to get the most out of costly Barrett’s oesophagus surveillance. Digestive and Liver Disease 2018; 50(9): 871 doi: 10.1016/j.dld.2018.04.012
|
| 3 |
Vinicius J. Campos, Guilherme S. Mazzini, José F. Juchem, Richard R. Gurski. Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett’s Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study. Journal of Gastrointestinal Surgery 2020; 24(1): 8 doi: 10.1007/s11605-019-04456-x
|
| 4 |
Henry Badgery, Matthew Read, Nicole N. Winter, Andrew C. F. Taylor, Michael W. Hii. The role of esophagectomy in the management of Barrett's esophagus with high‐grade dysplasia. Annals of the New York Academy of Sciences 2020; 1481(1): 72 doi: 10.1111/nyas.14439
|
| 5 |
Masashi ZUGUCHI, Reijiro SAITO, Yasushi KAWAHARADA, Yosuke KUBOTA, Yoshitaka ENOMOTO, Ken SAITO, Megumi ZUGUCHI, Satsuki TAKAHASHI. A Case of Barrett's Adenocarcinoma Associated with Systemic Sclerosis. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2019; 80(6): 1110 doi: 10.3919/jjsa.80.1110
|
| 6 |
John W. Peabody, Jamielyn D.C. Cruz, Divya Ganesan, David Paculdo, Rebecca J. Critchley-Thorne, Sachin Wani, Nicholas J. Shaheen. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB. Clinical and Translational Gastroenterology 2024; 15(1): e00644 doi: 10.14309/ctg.0000000000000644
|
| 7 |
Won-Tak Choi, Jia-Huei Tsai, Peter S Rabinovitch, Thomas Small, Danning Huang, Aras N Mattis, Sanjay Kakar. Diagnosis and risk stratification of Barrett’s dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue. Gut 2018; 67(7): 1229 doi: 10.1136/gutjnl-2017-313815
|
| 8 |
Muhannad Sarem, Francisco J. Martínez Cerezo, Maria Lujan Salvia Favieres, Rodolfo Corti. Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis. Gastroenterología y Hepatología 2023; 46(8): 637 doi: 10.1016/j.gastrohep.2022.10.002
|
| 9 |
Andrew J Henn, Kevin Y Song, Amy A Gravely, Hector Mesa, Shahnaz Sultan, Nicholas J Shaheen, Aasma Shaukat, Brian J Hanson. Persistent indefinite for dysplasia in Barrett’s esophagus is a risk factor for dysplastic progression to low-grade dysplasia. Diseases of the Esophagus 2020; 33(9) doi: 10.1093/dote/doaa015
|
| 10 |
Jagpal Singh Klair, Yousaf Zafar, Navroop Nagra, Arvind R. Murali, Mahendran Jayaraj, Dhruv Singh, Tarun Rustagi, Rajesh Krishnamoorthi. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett’s Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis. Digestive Diseases 2021; 39(6): 561 doi: 10.1159/000514786
|
| 11 |
Jon M. Davison, Maulin B. Shah, Christopher Deitrick, Jennifer Chennat, Ken E. Fasanella, Kevin McGrath. Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett’s esophagus risk stratification proficiency in independent pathology practices. Gastrointestinal Endoscopy 2018; 88(5): 807 doi: 10.1016/j.gie.2018.06.017
|
| 12 |
Ravi Vissapragada, Norma B. Bulamu, Roger Yazbeck, Jonathan Karnon, David I. Watson. A Markov cohort model for Endoscopic surveillance and management of Barrett’s esophagus. Healthcare Analytics 2024; 6: 100360 doi: 10.1016/j.health.2024.100360
|
| 13 |
Rena Yadlapati, Elizabeth Hubscher, Corey Pelletier, Rinu Jacob, Allison Brackley, Shailja Shah. Induction and maintenance of healing in erosive esophagitis in the United States. Expert Review of Gastroenterology & Hepatology 2022; 16(10): 967 doi: 10.1080/17474124.2022.2134115
|
| 14 |
Sagar N. Shah, Jennifer M. Kolb. Today's Toolbox for Barrett's Endotherapy. Techniques and Innovations in Gastrointestinal Endoscopy 2023; 25(2): 167 doi: 10.1016/j.tige.2023.02.001
|
| 15 |
K Y Song, A J Henn, A A Gravely, H Mesa, S Sultan, N J Shaheen, A Shaukat, B J Hanson. Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort. Diseases of the Esophagus 2019; doi: 10.1093/dote/doz061
|
| 16 |
Saurabh Chandan, Smit Deliwala, Babu P. Mohan, Daryl Ramai, Banreet Dhindsa, Jay Bapaye, Lena L. Kassab, Ojasvini Choudhry Chandan, Antonio Facciorusso, Douglas G. Adler. Vonoprazan versus lansoprazole in erosive esophagitis — A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Gastroenterology 2023; 42(4): 475 doi: 10.1007/s12664-023-01384-2
|
| 17 |
M. V. Shamal', A. I. Varabei, Zh. G. Maskalik. BARRETT’S ESOPHAGUS: CONTEMPORARY DIAGNOSTIC AND THERAPEUTIC APPROACHES. Hepatology and Gastroenterology 2019; 3(1): 103 doi: 10.25298/2616-5546-2019-3-1-103-108
|
| 18 |
Fumiaki Shiratori, Isamu Hoshino, Hisashi Gunji, Nobuhiro Takiguchi, Yoshihiro Nabeya, Hideaki Shimada. A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-00956-0
|
| 19 |
Ravi Vissapragada, Norma B. Bulamu, Christine Brumfitt, Jonathan Karnon, Roger Yazbeck, David I. Watson. Improving cost-effectiveness of endoscopic surveillance for Barrett’s esophagus by reducing low-value care: a review of economic evaluations. Surgical Endoscopy 2021; 35(11): 5905 doi: 10.1007/s00464-021-08646-0
|
| 20 |
Salih Samo, Ajay Bansal. The Risk of Barrett’s Esophagus Transforming to Esophageal Cancer. Foregut: The Journal of the American Foregut Society 2023; 3(1): 69 doi: 10.1177/26345161221143140
|
| 21 |
Lauren Caush, Jody Church, Stephen Goodall, Reginald V Lord. Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett’s esophagus with low-grade dysplasia in Australia. Diseases of the Esophagus 2025; 38(1) doi: 10.1093/dote/doae095
|
| 22 |
Muhannad Sarem, Francisco J. Martínez Cerezo, Maria Lujan Salvia Favieres, Rodolfo Corti. Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis. Gastroenterología y Hepatología (English Edition) 2023; 46(8): 637 doi: 10.1016/j.gastre.2022.10.016
|